Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, and Others), and Location of Testing (Laboratory Testing and POC Testing): Global Opportunity Analysis and Industry Forecast, 2018–2025
CHAPTER 1:INTRODUCTION
1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO PERSPECTIVE
CHAPTER 3:MARKET OVERVIEW
3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.MARKET DYNAMICS
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
CHAPTER 4:STD TESTING MARKET BY DISEASE TYPE
4.1.OVERVIEW
4.2. CHLAMYDIA
4.2.1.Key market trends, Growth factors and opportunities
4.2.2.Market size and forecast by region
4.2.3.Market volume and forecast by region
4.3. GONORRHEA
4.3.1.Key market trends, Growth factors and opportunities
4.3.2.Market size and forecast by region
4.3.3.Market volume and forecast by region
4.4. HERPES SIMPLEX VIRUS
4.4.1.Key market trends, Growth factors and opportunities
4.4.2.Market size and forecast by region
4.4.3.Market volume and forecast by region
4.5. SYPHILIS
4.5.1.Key market trends, Growth factors and opportunities
4.5.2.Market size and forecast by region
4.5.3.Market volume and forecast by region
4.6. HUMAN PAPILLOMA VIRUS
4.6.1.Key market trends, Growth factors and opportunities
4.6.2.Market size and forecast by region
4.6.3.Market volume and forecast by region
4.7. HUMAN IMMUNODEFICIENCY VIRUS
4.7.1.Key market trends, Growth factors and opportunities
4.7.2.Market size and forecast by region
4.7.3.Market volume and forecast by region
4.8. OTHERS
4.8.1.Key market trends, Growth factors and opportunities
4.8.2.Market size and forecast by region
4.8.3.Market volume and forecast by region
CHAPTER 5:STD TESTING MARKET BY LOCATION OF TESTING
5.1.OVERVIEW
5.2. LABORATORY TESTING
5.2.1.Key market trends, Growth factors and opportunities
5.2.2.Market size and forecast by region
5.2.3.Market volume and forecast by region
5.3. POINT OF CARE TESTING
5.3.1.Key market trends, Growth factors and opportunities
5.3.2.Market size and forecast by region
5.3.3.Market volume and forecast by region
CHAPTER 6:STD TESTING MARKET BY REGION
6.1.OVERVIEW
6.2.NORTH AMERICA
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast by Disease Type
6.2.3.Market size and forecast by Location of Testing
6.3.EUROPE
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast by Disease Type
6.3.3.Market size and forecast by Location of Testing
6.4.ASIA PACIFIC
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast by Disease Type
6.4.3.Market size and forecast by Location of Testing
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast by Disease Type
6.5.3.Market size and forecast by Location of Testing
CHAPTER 7:COMPANY PROFILES
7.1. ROCHE HOLDINGS AG
7.1.1.Company overview
7.1.2.Business performance
7.1.3.Key strategic moves and developments
7.2. BIOMERIEUX
7.2.1.Company overview
7.2.2.Business performance
7.2.3.Key strategic moves and developments
7.3. HOLOGIC INC
7.3.1.Company overview
7.3.2.Business performance
7.3.3.Key strategic moves and developments
7.4. BECTON DICKINSON COMPANY
7.4.1.Company overview
7.4.2.Business performance
7.4.3.Key strategic moves and developments
7.5. ORASURE
7.5.1.Company overview
7.5.2.Business performance
7.5.3.Key strategic moves and developments
7.6. DANAHER CORPORATION
7.6.1.Company overview
7.6.2.Business performance
7.6.3.Key strategic moves and developments
7.7. AFFYMETRIX
7.7.1.Company overview
7.7.2.Business performance
7.7.3.Key strategic moves and developments
7.8. ABBOTT LABORATORIES
7.8.1.Company overview
7.8.2.Business performance
7.8.3.Key strategic moves and developments
7.9. BIO-RAD LABORATORIES INC
7.9.1.Company overview
7.9.2.Business performance
7.9.3.Key strategic moves and developments
7.10. DIASORIN
7.10.1.Company overview
7.10.2.Business performance
7.10.3.Key strategic moves and developments
1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO PERSPECTIVE
CHAPTER 3:MARKET OVERVIEW
3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.MARKET DYNAMICS
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
CHAPTER 4:STD TESTING MARKET BY DISEASE TYPE
4.1.OVERVIEW
4.2. CHLAMYDIA
4.2.1.Key market trends, Growth factors and opportunities
4.2.2.Market size and forecast by region
4.2.3.Market volume and forecast by region
4.3. GONORRHEA
4.3.1.Key market trends, Growth factors and opportunities
4.3.2.Market size and forecast by region
4.3.3.Market volume and forecast by region
4.4. HERPES SIMPLEX VIRUS
4.4.1.Key market trends, Growth factors and opportunities
4.4.2.Market size and forecast by region
4.4.3.Market volume and forecast by region
4.5. SYPHILIS
4.5.1.Key market trends, Growth factors and opportunities
4.5.2.Market size and forecast by region
4.5.3.Market volume and forecast by region
4.6. HUMAN PAPILLOMA VIRUS
4.6.1.Key market trends, Growth factors and opportunities
4.6.2.Market size and forecast by region
4.6.3.Market volume and forecast by region
4.7. HUMAN IMMUNODEFICIENCY VIRUS
4.7.1.Key market trends, Growth factors and opportunities
4.7.2.Market size and forecast by region
4.7.3.Market volume and forecast by region
4.8. OTHERS
4.8.1.Key market trends, Growth factors and opportunities
4.8.2.Market size and forecast by region
4.8.3.Market volume and forecast by region
CHAPTER 5:STD TESTING MARKET BY LOCATION OF TESTING
5.1.OVERVIEW
5.2. LABORATORY TESTING
5.2.1.Key market trends, Growth factors and opportunities
5.2.2.Market size and forecast by region
5.2.3.Market volume and forecast by region
5.3. POINT OF CARE TESTING
5.3.1.Key market trends, Growth factors and opportunities
5.3.2.Market size and forecast by region
5.3.3.Market volume and forecast by region
CHAPTER 6:STD TESTING MARKET BY REGION
6.1.OVERVIEW
6.2.NORTH AMERICA
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast by Disease Type
6.2.3.Market size and forecast by Location of Testing
6.3.EUROPE
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast by Disease Type
6.3.3.Market size and forecast by Location of Testing
6.4.ASIA PACIFIC
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast by Disease Type
6.4.3.Market size and forecast by Location of Testing
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast by Disease Type
6.5.3.Market size and forecast by Location of Testing
CHAPTER 7:COMPANY PROFILES
7.1. ROCHE HOLDINGS AG
7.1.1.Company overview
7.1.2.Business performance
7.1.3.Key strategic moves and developments
7.2. BIOMERIEUX
7.2.1.Company overview
7.2.2.Business performance
7.2.3.Key strategic moves and developments
7.3. HOLOGIC INC
7.3.1.Company overview
7.3.2.Business performance
7.3.3.Key strategic moves and developments
7.4. BECTON DICKINSON COMPANY
7.4.1.Company overview
7.4.2.Business performance
7.4.3.Key strategic moves and developments
7.5. ORASURE
7.5.1.Company overview
7.5.2.Business performance
7.5.3.Key strategic moves and developments
7.6. DANAHER CORPORATION
7.6.1.Company overview
7.6.2.Business performance
7.6.3.Key strategic moves and developments
7.7. AFFYMETRIX
7.7.1.Company overview
7.7.2.Business performance
7.7.3.Key strategic moves and developments
7.8. ABBOTT LABORATORIES
7.8.1.Company overview
7.8.2.Business performance
7.8.3.Key strategic moves and developments
7.9. BIO-RAD LABORATORIES INC
7.9.1.Company overview
7.9.2.Business performance
7.9.3.Key strategic moves and developments
7.10. DIASORIN
7.10.1.Company overview
7.10.2.Business performance
7.10.3.Key strategic moves and developments
LIST OF TABLES
TABLE 1.GLOBAL STD TESTING MARKET, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 2.STD TESTING MARKET FOR CHLAMYDIA, BY REGION, 2017-2025 ($MILLION)
TABLE 3.STD TESTING MARKET FOR GONORRHEA, BY REGION, 2017-2025 ($MILLION)
TABLE 4.STD TESTING MARKET FOR HERPES SIMPLEX VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 5.STD TESTING MARKET FOR SYPHILIS, BY REGION, 2017-2025 ($MILLION)
TABLE 6.STD TESTING MARKET FOR HUMAN PAPILLOMA VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 7.STD TESTING MARKET FOR HUMAN IMMUNODEFICIENCY VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 8.STD TESTING MARKET FOR OTHERS, BY REGION, 2017-2025 ($MILLION)
TABLE 9.GLOBAL STD TESTING MARKET, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 10.STD TESTING MARKET FOR LABORATORY TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 11.STD TESTING MARKET FOR POINT OF CARE TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 12.STD TESTING MARKET FOR, BY REGION, 2017-2025 ($MILLION)
TABLE 13.NORTH AMERICA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 14.NORTH AMERICA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 15.NORTH AMERICA STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 16.EUROPE STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 17.EUROPE STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 18.EUROPE STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 19.ASIA PACIFIC STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 20.ASIA PACIFIC STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 21.ASIA PACIFIC STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 22.LAMEA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 23.LAMEA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 24.LAMEA STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 25.ROCHE HOLDINGS AG: COMPANY SNAPSHOT
TABLE 26.ROCHE HOLDINGS AG: OPERATING SEGMENTS
TABLE 27.BIOMERIEUX: COMPANY SNAPSHOT
TABLE 28.BIOMERIEUX: OPERATING SEGMENTS
TABLE 29.HOLOGIC INC: COMPANY SNAPSHOT
TABLE 30.HOLOGIC INC: OPERATING SEGMENTS
TABLE 31.BECTON DICKINSON COMPANY: COMPANY SNAPSHOT
TABLE 32.BECTON DICKINSON COMPANY: OPERATING SEGMENTS
TABLE 33.ORASURE: COMPANY SNAPSHOT
TABLE 34.ORASURE: OPERATING SEGMENTS
TABLE 35.DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 36.DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 37.AFFYMETRIX: COMPANY SNAPSHOT
TABLE 38.AFFYMETRIX: OPERATING SEGMENTS
TABLE 39.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 40.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 41.BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
TABLE 42.BIO-RAD LABORATORIES INC: OPERATING SEGMENTS
TABLE 43.DIASORIN: COMPANY SNAPSHOT
TABLE 44.DIASORIN: OPERATING SEGMENTS
TABLE 1.GLOBAL STD TESTING MARKET, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 2.STD TESTING MARKET FOR CHLAMYDIA, BY REGION, 2017-2025 ($MILLION)
TABLE 3.STD TESTING MARKET FOR GONORRHEA, BY REGION, 2017-2025 ($MILLION)
TABLE 4.STD TESTING MARKET FOR HERPES SIMPLEX VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 5.STD TESTING MARKET FOR SYPHILIS, BY REGION, 2017-2025 ($MILLION)
TABLE 6.STD TESTING MARKET FOR HUMAN PAPILLOMA VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 7.STD TESTING MARKET FOR HUMAN IMMUNODEFICIENCY VIRUS, BY REGION, 2017-2025 ($MILLION)
TABLE 8.STD TESTING MARKET FOR OTHERS, BY REGION, 2017-2025 ($MILLION)
TABLE 9.GLOBAL STD TESTING MARKET, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 10.STD TESTING MARKET FOR LABORATORY TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 11.STD TESTING MARKET FOR POINT OF CARE TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 12.STD TESTING MARKET FOR, BY REGION, 2017-2025 ($MILLION)
TABLE 13.NORTH AMERICA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 14.NORTH AMERICA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 15.NORTH AMERICA STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 16.EUROPE STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 17.EUROPE STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 18.EUROPE STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 19.ASIA PACIFIC STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 20.ASIA PACIFIC STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 21.ASIA PACIFIC STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 22.LAMEA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)
TABLE 23.LAMEA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)
TABLE 24.LAMEA STD TESTING, BY REGION, 2017-2025 ($MILLION)
TABLE 25.ROCHE HOLDINGS AG: COMPANY SNAPSHOT
TABLE 26.ROCHE HOLDINGS AG: OPERATING SEGMENTS
TABLE 27.BIOMERIEUX: COMPANY SNAPSHOT
TABLE 28.BIOMERIEUX: OPERATING SEGMENTS
TABLE 29.HOLOGIC INC: COMPANY SNAPSHOT
TABLE 30.HOLOGIC INC: OPERATING SEGMENTS
TABLE 31.BECTON DICKINSON COMPANY: COMPANY SNAPSHOT
TABLE 32.BECTON DICKINSON COMPANY: OPERATING SEGMENTS
TABLE 33.ORASURE: COMPANY SNAPSHOT
TABLE 34.ORASURE: OPERATING SEGMENTS
TABLE 35.DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 36.DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 37.AFFYMETRIX: COMPANY SNAPSHOT
TABLE 38.AFFYMETRIX: OPERATING SEGMENTS
TABLE 39.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 40.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 41.BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
TABLE 42.BIO-RAD LABORATORIES INC: OPERATING SEGMENTS
TABLE 43.DIASORIN: COMPANY SNAPSHOT
TABLE 44.DIASORIN: OPERATING SEGMENTS
